$RCKT
ROCKET PHARMACEUTICALS, INC.

2024 Q1 Form 10-K Financial Statement

#000095017024021096 Filed on February 27, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $22.15M $21.54M $73.32M
YoY Change 39.97% 25.61% 31.93%
% of Gross Profit
Research & Development $45.23M $41.74M $186.3M
YoY Change -2.47% -16.57% 12.55%
% of Gross Profit
Depreciation & Amortization $1.700M $1.935M $4.900M
YoY Change 1.61% 8.83% -21.8%
% of Gross Profit
Operating Expenses $67.38M $63.28M $259.7M
YoY Change 8.33% -5.81% 15.74%
Operating Profit -$67.38M -$259.7M
YoY Change 8.33% 15.74%
Interest Expense $471.0K $344.0K $1.875M
YoY Change 0.64% -55.78% 0.7%
% of Operating Profit
Other Income/Expense, Net $2.763M $3.275M $10.65M
YoY Change 14.22% 107.15% 329.48%
Pretax Income -$62.05M -$59.66M -$245.6M
YoY Change 6.38% -10.59% 10.7%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$62.05M -$59.66M -$245.6M
YoY Change 6.38% -10.59% 10.7%
Net Earnings / Revenue
Basic Earnings Per Share -$0.66 -$2.92
Diluted Earnings Per Share -$0.66 -$0.64 -$2.92
COMMON SHARES
Basic Shares Outstanding 90.50M 90.16M 84.01M
Diluted Shares Outstanding 93.55M 84.01M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $330.3M $373.2M $373.2M
YoY Change -0.23% 4.71% 4.71%
Cash & Equivalents $35.28M $55.90M $55.90M
Short-Term Investments $295.0M $317.3M $317.3M
Other Short-Term Assets $14.85M $5.047M $5.047M
YoY Change 113.64% -34.16% -34.16%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $345.2M $378.2M $378.2M
YoY Change 2.11% 3.89% 3.89%
LONG-TERM ASSETS
Property, Plant & Equipment $39.34M $39.17M $87.59M
YoY Change 28.6% 35.03% 12.81%
Goodwill $39.20M $39.15M
YoY Change 0.0% -0.12%
Intangibles $25.15M $25.15M
YoY Change -2.23% -2.23%
Long-Term Investments $0.00 $34.32M $34.32M
YoY Change -100.0% -20.7% -20.7%
Other Assets $1.895M $1.905M $1.905M
YoY Change 5.34% -2.21% -2.21%
Total Long-Term Assets $154.3M $188.1M $188.1M
YoY Change -12.7% 0.2% 0.2%
TOTAL ASSETS
Total Short-Term Assets $345.2M $378.2M $378.2M
Total Long-Term Assets $154.3M $188.1M $188.1M
Total Assets $499.4M $566.3M $566.3M
YoY Change -2.98% 2.63% 2.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.14M
YoY Change
Accrued Expenses $28.40M $31.81M $31.81M
YoY Change 2.2% -9.54% -9.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.808M $1.791M $1.791M
YoY Change 3.43% 3.17% 3.17%
Total Short-Term Liabilities $32.96M $48.51M $48.51M
YoY Change 5.61% 23.84% 23.84%
LONG-TERM LIABILITIES
Long-Term Debt $19.36M $19.35M $19.35M
YoY Change 0.36% 0.44% 0.44%
Other Long-Term Liabilities $1.906M $2.936M $5.909M
YoY Change 1.65% 13.14% 60.44%
Total Long-Term Liabilities $1.906M $2.936M $25.26M
YoY Change 1.65% 13.14% 10.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $32.96M $48.51M $48.51M
Total Long-Term Liabilities $1.906M $2.936M $25.26M
Total Liabilities $57.94M $73.77M $73.77M
YoY Change 3.68% 18.75% 18.75%
SHAREHOLDERS EQUITY
Retained Earnings -$1.020B -$959.4M
YoY Change 32.11% 34.41%
Common Stock $906.0K $903.0K
YoY Change 12.69% 14.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $441.5M $492.6M $492.6M
YoY Change
Total Liabilities & Shareholders Equity $499.4M $566.3M $566.3M
YoY Change -2.98% 2.63% 2.63%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$62.05M -$59.66M -$245.6M
YoY Change 6.38% -10.59% 10.7%
Depreciation, Depletion And Amortization $1.700M $1.935M $4.900M
YoY Change 1.61% 8.83% -21.8%
Cash From Operating Activities -$56.86M -$29.34M -$194.9M
YoY Change -1.22% -47.63% 9.42%
INVESTING ACTIVITIES
Capital Expenditures $2.035M $4.647M $16.44M
YoY Change -32.5% 42.37% 96.65%
Acquisitions
YoY Change
Other Investing Activities $37.07M -$136.2M -$81.59M
YoY Change -210.0% 29.28% 34.41%
Cash From Investing Activities $35.03M -$140.8M -$98.07M
YoY Change -195.41% 29.67% 41.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.184M 391.0K 208.4M
YoY Change -93.55% -99.64% 34.2%
NET CHANGE
Cash From Operating Activities -56.86M -29.34M -194.9M
Cash From Investing Activities 35.03M -140.8M -98.07M
Cash From Financing Activities 1.184M 391.0K 208.4M
Net Change In Cash -20.64M -169.8M -84.58M
YoY Change -72.82% 202.23% -8.24%
FREE CASH FLOW
Cash From Operating Activities -$56.86M -$29.34M -$194.9M
Capital Expenditures $2.035M $4.647M $16.44M
Free Cash Flow -$58.89M -$33.99M -$211.4M
YoY Change -2.78% -42.67% 13.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001281895
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 us-gaap Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#GoodwillAndIntangibleAssetImpairment
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-36829
CY2023 dei Entity Registrant Name
EntityRegistrantName
Rocket Pharmaceuticals, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3475813
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
9 Cedarbrook Drive
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Cranbury
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08512
CY2023 dei City Area Code
CityAreaCode
609
CY2023 dei Local Phone Number
LocalPhoneNumber
659-8001
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2023 dei Trading Symbol
TradingSymbol
RCKT
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
1200000000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
90504248
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
274
CY2023 dei Auditor Name
AuditorName
EISNERAMPER LLP
CY2023 dei Auditor Location
AuditorLocation
Iselin, New Jersey
CY2023 dei Auditor Name
AuditorName
EISNERAMPER LLP
CY2023 dei Auditor Location
AuditorLocation
Iselin, New Jersey
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55904000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
140517000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
317271000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
215877000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5047000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7666000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
378222000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
364060000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39172000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29009000
CY2023Q4 us-gaap Goodwill
Goodwill
39154000
CY2022Q4 us-gaap Goodwill
Goodwill
39154000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
25150000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
25724000
CY2023Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1372000
CY2022Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1340000
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
533000
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
608000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
34320000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
43276000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3901000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1972000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
44517000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
46664000
CY2023Q4 us-gaap Assets
Assets
566341000
CY2022Q4 us-gaap Assets
Assets
551807000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
45789000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
36660000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
925000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
773000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1791000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1736000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
48505000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
39169000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2973000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1088000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
19353000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
19269000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2936000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2595000
CY2023Q4 us-gaap Liabilities
Liabilities
73767000
CY2022Q4 us-gaap Liabilities
Liabilities
62121000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90282267
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79123312
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90282267
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79120741
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
903000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
791000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2571
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
47000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1450722000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1203074000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
319000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-357000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-959370000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-713775000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
492574000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
489686000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
566341000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
551807000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
186342000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
165570000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
125476000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
73317000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
58773000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41772000
CY2023 us-gaap Operating Expenses
OperatingExpenses
259659000
CY2022 us-gaap Operating Expenses
OperatingExpenses
224343000
CY2021 us-gaap Operating Expenses
OperatingExpenses
167248000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-259659000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-224343000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-167248000
CY2022 rckt Research And Development Incentives
ResearchAndDevelopmentIncentives
500000
CY2021 rckt Research And Development Incentives
ResearchAndDevelopmentIncentives
1000000
CY2023 us-gaap Interest Expense
InterestExpense
1875000
CY2022 us-gaap Interest Expense
InterestExpense
1862000
CY2021 us-gaap Interest Expense
InterestExpense
2977000
CY2023 us-gaap Interest And Other Income
InterestAndOtherIncome
5288000
CY2022 us-gaap Interest And Other Income
InterestAndOtherIncome
3889000
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
3068000
CY2023 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
10651000
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-47000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-2912000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-245595000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-221863000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-169069000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.92
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.92
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.26
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.26
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.67
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.67
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84009004
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84009004
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68148925
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68148925
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63235417
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63235417
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-245595000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-221863000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-169069000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
676000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-196000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-119000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-244919000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-222059000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-169188000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
503519000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11327000
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
40694000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
26354000
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
12781000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-119000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29237000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-169069000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
454724000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
108138000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
631000
CY2022 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
70724000
CY2022 rckt Stock Issued During Period Value At The Market Offering Programs
StockIssuedDuringPeriodValueAtTheMarketOfferingPrograms
46566000
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
47000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-196000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31009000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-221863000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
489686000
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
188885000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2231000
CY2023 rckt Stock Issued During Period Value Common Stock Warrants Exercised
StockIssuedDuringPeriodValueCommonStockWarrantsExercised
7000
CY2023 rckt Stock Issued During Period Value At The Market Offering Programs
StockIssuedDuringPeriodValueAtTheMarketOfferingPrograms
17222000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
676000
CY2023 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
56000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39406000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-245595000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
492574000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-245595000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-221863000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-169069000
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
753000
CY2023 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
4944000
CY2022 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3932000
CY2021 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3240000
CY2023 rckt Adjustment Of Right Of Use Assets
AdjustmentOfRightOfUseAssets
2154000
CY2022 rckt Adjustment Of Right Of Use Assets
AdjustmentOfRightOfUseAssets
2334000
CY2021 rckt Adjustment Of Right Of Use Assets
AdjustmentOfRightOfUseAssets
2133000
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
574000
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2021 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2023 rckt Property Plant And Equipment Write Down
PropertyPlantAndEquipmentWriteDown
311000
CY2022 rckt Property Plant And Equipment Write Down
PropertyPlantAndEquipmentWriteDown
236000
CY2021 rckt Property Plant And Equipment Write Down
PropertyPlantAndEquipmentWriteDown
261000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
39406000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
31009000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
29237000
CY2023 rckt Accretion Amortization Of Discounts And Premiums Excluding Accretion Income Related To Cash Equivalents Investments
AccretionAmortizationOfDiscountsAndPremiumsExcludingAccretionIncomeRelatedToCashEquivalentsInvestments
10168000
CY2022 rckt Accretion Amortization Of Discounts And Premiums Excluding Accretion Income Related To Cash Equivalents Investments
AccretionAmortizationOfDiscountsAndPremiumsExcludingAccretionIncomeRelatedToCashEquivalentsInvestments
-134000
CY2021 rckt Accretion Amortization Of Discounts And Premiums Excluding Accretion Income Related To Cash Equivalents Investments
AccretionAmortizationOfDiscountsAndPremiumsExcludingAccretionIncomeRelatedToCashEquivalentsInvestments
-2887000
CY2023 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
0
CY2022 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
0
CY2021 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
12781000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2694000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3593000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1307000
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10147000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9674000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-84581000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-92180000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-64629000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141857000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
234037000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4827000
CY2023 rckt Increase Decrease In Operating Lease Liability And Right Of Use Assets Net
IncreaseDecreaseInOperatingLeaseLiabilityAndRightOfUseAssetsNet
137000
CY2022 rckt Increase Decrease In Operating Lease Liability And Right Of Use Assets Net
IncreaseDecreaseInOperatingLeaseLiabilityAndRightOfUseAssetsNet
-120000
CY2021 rckt Increase Decrease In Operating Lease Liability And Right Of Use Assets Net
IncreaseDecreaseInOperatingLeaseLiabilityAndRightOfUseAssetsNet
-11000
CY2023 rckt Increase Decrease In Finance Lease Liabilities
IncreaseDecreaseInFinanceLeaseLiabilities
139000
CY2022 rckt Increase Decrease In Finance Lease Liabilities
IncreaseDecreaseInFinanceLeaseLiabilities
172000
CY2021 rckt Increase Decrease In Finance Lease Liabilities
IncreaseDecreaseInFinanceLeaseLiabilities
201000
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
341000
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-57000
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-56000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-194916000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-178142000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-121163000
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
390920000
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
376327000
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
245875000
CY2023 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
309326000
CY2022 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
272894000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
272443000
CY2023 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0
CY2022 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
42726000
CY2021 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0
CY2023 rckt Payments To Acquire Right Of Use Asset
PaymentsToAcquireRightOfUseAsset
36000
CY2022 rckt Payments To Acquire Right Of Use Asset
PaymentsToAcquireRightOfUseAsset
261000
CY2021 rckt Payments To Acquire Right Of Use Asset
PaymentsToAcquireRightOfUseAsset
95000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16436000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8358000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7620000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-98066000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69326000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18853000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2231000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
631000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11327000
CY2023 rckt Payments For Repurchase Treasury Stock
PaymentsForRepurchaseTreasuryStock
0
CY2022 rckt Payments For Repurchase Treasury Stock
PaymentsForRepurchaseTreasuryStock
47000
CY2021 rckt Payments For Repurchase Treasury Stock
PaymentsForRepurchaseTreasuryStock
0
CY2023 us-gaap Proceeds From Sale Of Treasury Stock
ProceedsFromSaleOfTreasuryStock
56000
CY2022 us-gaap Proceeds From Sale Of Treasury Stock
ProceedsFromSaleOfTreasuryStock
0
CY2021 us-gaap Proceeds From Sale Of Treasury Stock
ProceedsFromSaleOfTreasuryStock
0
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
7000
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
208401000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
155288000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
37681000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
298666000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57276000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141857000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
234037000
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1077000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2095000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
728000
CY2023 rckt Non Cash Operating Lease Liability
NonCashOperatingLeaseLiability
2929000
CY2022 rckt Non Cash Operating Lease Liability
NonCashOperatingLeaseLiability
0
CY2021 rckt Non Cash Operating Lease Liability
NonCashOperatingLeaseLiability
0
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
676000
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-196000
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-119000
CY2023 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0
CY2022 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
40694000
CY2023 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
0
CY2022 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
70724000
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
0
CY2023 rckt Reclassification Of Construction In Process To Finance Right Of Use Asset
ReclassificationOfConstructionInProcessToFinanceRightOfUseAsset
0
CY2022 rckt Reclassification Of Construction In Process To Finance Right Of Use Asset
ReclassificationOfConstructionInProcessToFinanceRightOfUseAsset
261000
CY2021 rckt Reclassification Of Construction In Process To Finance Right Of Use Asset
ReclassificationOfConstructionInProcessToFinanceRightOfUseAsset
98000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0
CY2021 us-gaap Interest Paid Net
InterestPaidNet
148000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-959400000
CY2023Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
407500000
CY2023Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
407500000
CY2023Q4 us-gaap Cash
Cash
394400000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:24.5pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions reflected in these consolidated financial statements include but are not limited to goodwill and intangible asset impairments, the accrual of research and development (“R&amp;D”) </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">expenses, the valuation of equity transactions, and stock-based awards. Changes in estimates and assumptions are reflected in reported results in the period in which they become known. Actual results could differ from those estimates.</span></p>
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55904000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
140517000
CY2023Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1372000
CY2022Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1340000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57276000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141857000
CY2023 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2022 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
700000
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-200000
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-100000
CY2023 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2022 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
600000
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
25724000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53204000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38102000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14032000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9093000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39172000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29009000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4900000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3900000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3200000
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
25150000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
25150000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
25724000
CY2023Q4 us-gaap Goodwill
Goodwill
39200000
CY2022Q4 us-gaap Goodwill
Goodwill
39200000
CY2021Q4 us-gaap Goodwill
Goodwill
30815000
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
8339000
CY2023Q4 us-gaap Goodwill
Goodwill
39154000
CY2022Q4 us-gaap Goodwill
Goodwill
39154000
CY2023Q4 rckt Research And Development Costs Current
ResearchAndDevelopmentCostsCurrent
13867000
CY2022Q4 rckt Research And Development Costs Current
ResearchAndDevelopmentCostsCurrent
19100000
CY2023Q4 rckt Investment Payable Current
InvestmentPayableCurrent
13137000
CY2022Q4 rckt Investment Payable Current
InvestmentPayableCurrent
0
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9930000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10006000
CY2023Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
1077000
CY2022Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
2095000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6006000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1436000
CY2023Q4 rckt Acquisition Expenses Current
AcquisitionExpensesCurrent
0
CY2022Q4 rckt Acquisition Expenses Current
AcquisitionExpensesCurrent
1153000
CY2023Q4 us-gaap Regulatory Liability Current
RegulatoryLiabilityCurrent
0
CY2022Q4 us-gaap Regulatory Liability Current
RegulatoryLiabilityCurrent
597000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1772000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2273000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
45789000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
36660000
CY2023Q4 rckt Investment Payable Current
InvestmentPayableCurrent
13100000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023 rckt Common Stock Voting Rights Number Of Votes Per Share
CommonStockVotingRightsNumberOfVotesPerShare
1
CY2023 us-gaap Proceeds From Sale Of Treasury Stock
ProceedsFromSaleOfTreasuryStock
60000.00
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.37
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
39406000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31009000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29237000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
39406000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31009000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29237000
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5715078
CY2021 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
12800000
CY2022 rckt Stock Issued During Shares Common Stock Warrant Exercised
StockIssuedDuringSharesCommonStockWarrantExercised
0
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-245595000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-221863000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-169069000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84009004
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84009004
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68148925
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68148925
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63235417
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63235417
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.92
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.92
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.26
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.26
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.67
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.67
CY2023 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2588123
CY2022 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2721267
CY2021 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1218038
CY2023 rckt Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Units Exercisable For Common Shares
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockUnitsExercisableForCommonShares
1490357
CY2022 rckt Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Units Exercisable For Common Shares
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockUnitsExercisableForCommonShares
992874
CY2021 rckt Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Units Exercisable For Common Shares
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockUnitsExercisableForCommonShares
23500
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
14863996
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
13138870
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
11143761
CY2023 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
18942476
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
16853011
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12385299
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.173
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.169
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.13
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.014
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.001
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.001
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.001
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.001
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.015
CY2023 rckt Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
0.017
CY2022 rckt Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
0
CY2021 rckt Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
0
CY2023 rckt Effective Income Tax Rate Reconciliation Transfer Pricing Adjustments
EffectiveIncomeTaxRateReconciliationTransferPricingAdjustments
0
CY2022 rckt Effective Income Tax Rate Reconciliation Transfer Pricing Adjustments
EffectiveIncomeTaxRateReconciliationTransferPricingAdjustments
0
CY2021 rckt Effective Income Tax Rate Reconciliation Transfer Pricing Adjustments
EffectiveIncomeTaxRateReconciliationTransferPricingAdjustments
-0.228
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.07
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.063
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.046
CY2023 rckt Effective Income Tax Rate Reconciliation At Federal Net Operating Loss True Up Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalNetOperatingLossTrueUpIncomeTaxRate
0.003
CY2022 rckt Effective Income Tax Rate Reconciliation At Federal Net Operating Loss True Up Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalNetOperatingLossTrueUpIncomeTaxRate
-0.027
CY2021 rckt Effective Income Tax Rate Reconciliation At Federal Net Operating Loss True Up Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalNetOperatingLossTrueUpIncomeTaxRate
0
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.067
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.087
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.002
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.01
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q4 rckt Deferred Tax Assets Tax Credit Carryforwards Research And Development
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment
20984000
CY2022Q4 rckt Deferred Tax Assets Tax Credit Carryforwards Research And Development
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment
20984000
CY2021Q4 rckt Deferred Tax Assets Tax Credit Carryforwards Research And Development
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment
35766000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
45313000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
33718000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
26789000
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
17205000
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
19085000
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
19753000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
28499000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
19781000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
11552000
CY2023Q4 rckt Deferred Tax Assets Warrants
DeferredTaxAssetsWarrants
9283000
CY2022Q4 rckt Deferred Tax Assets Warrants
DeferredTaxAssetsWarrants
8390000
CY2021Q4 rckt Deferred Tax Assets Warrants
DeferredTaxAssetsWarrants
8382000
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
5787000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
5424000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
0
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
8086000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
6332000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
8881000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
108472000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
91263000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
93361000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1061000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1061000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
17200000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-2100000
CY2023Q4 rckt Annual Limitations Under Section382 Of The Internal Revenue Code Amount
AnnualLimitationsUnderSection382OfTheInternalRevenueCodeAmount
1700000
CY2023 rckt Markup Expenses Interest Rate
MarkupExpensesInterestRate
0.10
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2024-10-31
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
200000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
200000
CY2023 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
2300000
CY2022 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
1200000
CY2021 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
1100000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
1400000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
800000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
600000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
1377000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
818000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
645000
CY2023 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2154000
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2139000
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2140000
CY2023 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1875000
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1861000
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1845000
CY2023 us-gaap Lease Cost
LeaseCost
5406000
CY2022 us-gaap Lease Cost
LeaseCost
4818000
CY2021 us-gaap Lease Cost
LeaseCost
4630000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
931000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
567000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
571000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
506000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
522000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2419000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5516000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1618000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3898000
CY2023Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1791000
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1856000
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
1912000
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
1969000
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
2028000
CY2023Q4 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
41003000
CY2023Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
50559000
CY2023Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
29415000
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
21144000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3901000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1972000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
925000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
773000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2973000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1088000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3898000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1861000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
44517000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
46664000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1791000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1736000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
19353000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
19269000
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
21144000
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
21005000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
1229000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
938000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
655000
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1736000
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1689000
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1644000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y9M18D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P20Y8M12D
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P21Y8M12D
CY2021Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P22Y8M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0832
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0644
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0446
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0896
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0869
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0896
CY2021 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
12800000
CY2023 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
20000.00
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.04
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1400000
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
900000
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
600000

Files In Submission

Name View Source Status
0000950170-24-021096-index-headers.html Edgar Link pending
0000950170-24-021096-index.html Edgar Link pending
0000950170-24-021096.txt Edgar Link pending
0000950170-24-021096-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img172964561_0.jpg Edgar Link pending
img172964561_1.jpg Edgar Link pending
img172964561_2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
rckt-20231231.htm Edgar Link pending
rckt-20231231.xsd Edgar Link pending
rckt-ex10_13.htm Edgar Link pending
rckt-ex10_23.htm Edgar Link pending
rckt-ex21_1.htm Edgar Link pending
rckt-ex23_1.htm Edgar Link pending
rckt-ex31_1.htm Edgar Link pending
rckt-ex31_2.htm Edgar Link pending
rckt-ex32_1.htm Edgar Link pending
rckt-ex97.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
rckt-20231231_htm.xml Edgar Link completed